Abstract
Positron emission tomography/computed tomography with the use of 18F-fluorodeoxyglucose (18F-FDG PET/CT) is an imaging modality that combines both functional and anatomical information. The combination of PET with CT has been established as an imaging modality and is currently widely used in oncology. Bone and soft tissue tumors, as of course the majority of tumors, are characterized of multiple metabolic and molecular alterations, which allow imaging with positron emitters. These alterations include increased glucolysis, increased amino acid, and increased nucleic acid metabolic activity.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Schwarzbach MHM, Hinz U, Dimitrakopoulou-Strauss A et al (2005) Prognostic significance of preoperative (18-F)fluorodeoxyglucose (FDG) positron emission tomography (PET) imaging in patients with resectable soft tissue sarcomas. Ann Surg 241:286–294
Fuglø HM, Jørgensen SM, Loft A et al (2012) The diagnostic and prognostic value of 18F-FDG PET/CT in the initial assessment of high-grade bone and soft tissue sarcoma. A retrospective study of 89 patients. Eur J Nucl Med Mol Imaging 39:1416–1424
Tateishi U, Yamaguchi U, Seki K et al (2007) Bone and soft-tissue sarcoma: preoperative staging with fluorine 18 fluorodeoxyglucose PET/CT and conventional imaging. Radiology 245(3):839–847
Franzius C, Sciuk J, Daldrup-Link HE et al (2000) FDG-PET for detection of osseous metastases from malignant primary bone tumours: comparison with bone scintigraphy. Eur J Nucl Med 27:1305–1311
Völker T, Denecke T, Steffen I et al (2007) Positron emission tomography for staging of pediatric sarcoma patients: results of a prospective multicenter trial. J Clin Oncol 25:5435–5441
Franzius C, Daldrup-Link HE, Sciuk J et al (2001) FDG-PET for detection of pulmonary metastases from malignant primary bone tumors: comparison with spiral CT. Ann Oncol 12:479–486
Herrmann K, Benz M, Czernin J et al (2012) 18F-FDG-PET/CT imaging as an early survival predictor in patients with primary high-grade soft tissue sarcomas undergoing neoadjuvant therapy. Clin Cancer Res 18:2024–2031
Fendler WP, Lehmann M, Todica A et al (2015) PET response criteria in solid tumors predicts progression-free survival and time to local or distant progression after chemotherapy with regional hyperthermia for soft-tissue-sarcoma. J Nucl Med 56:530–537
Koshkin V, Bolejack V, Schwartz L et al (2016) Assessment of imaging modalities and response metrics in Ewing sarcoma: correlation with survival. J Clin Oncol 34:3680–3685
Treglia G, Mirk P, Stefanelli A et al (2012) 18F-Fluorodeoxyglucose positron emission tomography in evaluating treatment response to imatinib or other drugs in gastrointestinal stromal tumors: a systematic review. Clin Imaging 36:167–175
Holdsworth CH, Badawi RD, Manola JB et al (2007) CT and PET: early prognostic indicators of response to imatinib mesylate in patients with gastrointestinal stromal tumor. AJR Am J Roentgenol 189:W324–W330
Demetri GD, Heinrich MC, Fletcher JA et al (2009) Molecular target modulation, imaging, and clinical evaluation of gastrointestinal stromal tumor patients treated with sunitinib malate after imatinib failure. Clin Cancer Res 15:5902–5909
Fuster D, Ayuso JR, Poveda A et al (2011) Value of FDG-PET for monitoring treatment response in patients with advanced GIST refractory to high-dose imatinib. A multicenter GEIS study. Q J Nucl Med Mol Imaging 55:680–687
Fendler WP, Chalkidis RP, Ilhan H et al (2015) Evaluation of several FDG parameters for prediction of soft tissue tumor grade at primary diagnosis and recurrence. Eur Radiol 25:2214–2221
Miyake KK, Nakamoto Y, Mikami Y et al (2016) The predictive value of preoperative 18F-fluorodeoxyglucose PET for postoperative recurrence in patients with localized primary gastrointestinal stromal tumor. Eur Radiol 26:4664–4674
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Chatziioannou, S.N., Pianou, N.K. (2018). Positron Emission Tomography in Bone and Soft Tissue Tumors. In: Gouliamos, A., Andreou, J., Kosmidis, P. (eds) Imaging in Clinical Oncology. Springer, Cham. https://doi.org/10.1007/978-3-319-68873-2_12
Download citation
DOI: https://doi.org/10.1007/978-3-319-68873-2_12
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-68872-5
Online ISBN: 978-3-319-68873-2
eBook Packages: MedicineMedicine (R0)